文献速递间质性肺疾病

2008至2018年英格兰特发性肺纤维化发病率、患病率与死亡率:队列研究

Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
PubMed 文献 · Thorax · 2024-06-14

该队列研究利用临床实践研究数据链Aurum与医院统计链接数据,采用四种经验证的诊断编码算法估算英格兰2008至2018年特发性肺纤维化(IPF)的发病率与患病率,并基于国家统计局登记的死亡数据估算死亡率。结果显示,在最佳定义下发病率在整个研究期间上升,2018年死亡率达7.9/10万人年,较2008年上升53%。按此推算,2018年英格兰每年新发IPF约8000–9000例,高于既往报告的5000–6000例。

要点

  • 采用最佳定义时,英格兰IPF发病率在研究期间持续上升。
  • 2018年IPF死亡率为7.9/10万人年,2008至2018年上升53%。
  • 估算2018年英格兰每年新发IPF约8000–9000例,高于既往报告。

核心结论

  • 采用最佳定义时,英格兰IPF发病率在研究期间持续上升,且估算的新发病例数高于既往报告。
  • IPF死亡率在2008至2018年间上升53%,2018年达7.9/10万人年。

研究设计与样本

  • 基于临床实践研究数据链Aurum与医院统计链接数据的队列研究。
  • 采用四种经验证的诊断编码算法估算发病率与患病率。
  • 利用国家统计局登记的死亡数据估算IPF死亡率。

主要发现

  • Aurum窄定义发病率从3/10万人年升至6.1/10万人年,增幅100%。
  • Aurum宽定义发病率从22.4/10万人年升至28.6/10万人年,增幅25%。
  • 基于医院统计的定义显示同期发病率下降,且介于Aurum两种定义之间。
  • 2018年IPF死亡率为7.9/10万人年,2008至2018年上升53%。
  • 按最佳估算,2018年英格兰每年新发IPF约8000–9000例。

临床怎么用

  • IPF新发病例数增加影响未来卫生服务规划与资源配置。
  • 临床与公共卫生层面需关注IPF疾病负担上升趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Owing to discrepancies in methodologies and how idiopathic pulmonary fibrosis (IPF) is diagnosed it is challenging to establish a consistent understanding of the disease burden In the UK, over 10 years ago, the incidence and prevalence of IPF were reported as 2.8-8.7 per 100 000 person-years (from 2000 to 2012) and 39 per 100 000 persons (in 2012), respectively. Here, we estimated the incidence and prevalence of IPF in England from 2008 to 2018 and investigated IPF mortality. METHODS: Using Clinical Practice Research Datalink Aurum and Hospital Episode Statistics (HES) linked datasets, we estimated incidence and prevalence using four validated diagnostic-code-based algorithms. Using the registered number of deaths (from Office of National Statistics) with the underlying cause being recorded as IPF, we estimated IPF mortality for the same period. RESULTS: Using Aurum-based definitions, incidence increased over time by 100% for Aurum narrow (3-6.1 per 100 000 person-years) and by 25% for Aurum broad (22.4-28.6 per 100 000 person-years). However, using HES-based definitions showed a decrease in incidence over the same period and lay between the two extremes derived for Aurum-based definition. IPF mortality in 2018 was 7.9 per 100 000 person-years and increased by 53% between 2008 and 2018. INTERPRETATION: When using best-case definitions, incidence rose throughout the study period. Scaling this to England's population (2018), our best estimate would be in the range of 8000-9000 new cases per year which is higher than previously reported estimates (5000-6000). This increased burden in the new cases of IPF each year impacts future health service planning and resource allocation.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Gupta R, Morgan AD, George PM, et al. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study. Thorax. 2024. PMID: 38688708. doi:10.1136/thorax-2023-220887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。